National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
35Dispensed price for supply of related pharmaceutical benefit
Start here
Get a plain-English read of 35
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
35 Dispensed price for supply of related pharmaceutical benefit
(1) The dispensed price for a special arrangement supply of a related pharmaceutical benefit that is a listed brand of a pharmaceutical item is as follows: (a) if the quantity of the benefit supplied is equal to a multiple of a pack quantity of the benefit—the sum of the approved ex‑manufacturer price or the proportional ex‑manufacturer price (as applicable) for each pack quantity; (b) if the quantity of the benefit supplied is less than a pack quantity of the benefit (a broken quantity)—the amount worked out in accordance with subsection (2); (c) if neither paragraph (a) or (b) applies to the quantity of the benefit supplied—the sum of: (i) the approved ex‑manufacturer price or the proportional ex‑manufacturer price (as applicable) for each pack quantity; and (ii) the amount calculated in accordance with subsection (2) for the remainder of the quantity that is a broken quantity. (2) For the purposes of paragraph (1)(b) and subparagraph (1)(c)(ii), the amount for a broken quantity is worked out by: (a) dividing the quantity or number of units in the broken quantity by the pack quantity, expressed as a percentage to 2 decimal places; and (b) applying that percentage to the approved ex‑manufacturer price or proportional ex‑manufacturer price (as applicable) for the pack quantity. (3) The dispensed price under subsection (1) is rounded to the nearest cent (with a half cent being rounded up).